
Advertisement
Insurers in Britain are planning to impose higher premiums on women who have not tested themselves for breast cancer. Insurers have approached government regulators in this regard and are asking that women test themselves for the BRCA1 and BRCA2 genetic mutations, which play a huge role in the development of breast and ovarian cancers.
Currently, the insurance industry cannot ask for genetic results until 2011, the only disease that forms an exception is Huntington's disease. But this new move met with criticism from campaigners, Dr Helen Wallace, deputy director of GeneWatch UK,
said, "Genetic testing should not become a vetting tool for employers and insurance companies." The Association of British Insurers (ABI) is expected to petition the Genetics and Insurance Committee to implement these new tests, "We are looking to get approval for the breast cancer test by the end of the year," Harpal Karlcut, chairman of the ABI genetic working party, said. But a team of scientists and campaigners are to meet the government asking it to ban such applications.
Advertisement
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.

Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.

Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.